SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — George H. W. Bush Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientGeorge H. W. Bush
Date of birth1924-06-12
IdentifiersMRN HR-ML018-SYN-TD; SSN (made up) 000-18-7245
Document date2026-11-01
AuthorDouglas Whitford, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Post-hospital visit for new atrial fibrillation, with thyroid tests showing hyperthyroidism. Concerns: New irregular heartbeat that began as unusual tiredness on a run; wants to know whether he can keep running; Wants to get back to a full working schedule and to exercise as soon as it is safe. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Metoprolol succinate extended-release 50 mg oral tablet, one tablet by mouth daily (started in hospital)One tablet each morningOral route1991-05-05 to 1991-07-17stoppedS
Metoprolol succinate extended-release 25 mg oral tablet, one tablet by mouth daily (taper)One tablet each morning for eight weeks, then stopOral route1991-07-17 to 1991-09-11stoppedS
Apixaban 5 mg oral tablet, one tablet by mouth twice daily (started in hospital)One tablet twice dailyOral route1991-05-05 to 1991-09-11stoppedS
Methimazole 10 mg oral tablet, two tablets (20 mg) by mouth dailyTwo tablets once daily; stop three days before radioactive iodineOral route1991-05-08 to 1991-05-26completedS
Levothyroxine 75 mcg oral tablet, one tablet by mouth daily before breakfastOne tablet on an empty stomach 30 to 60 minutes before breakfastOral route1991-07-17 to 1991-09-11stoppedS
Levothyroxine 100 mcg oral tablet, one tablet by mouth daily before breakfastOne tablet on an empty stomach 30 to 60 minutes before breakfastOral route1991-09-11activeS

Procedures

ProcedureDatesStatusEvidence
Transthoracic echocardiogram in hospital: normal chamber sizes, including the left atrium, normal valves, and left ventricular ejection fraction 60 percent1991-05-05 to 1991-05-05completedS
12-lead ECG at intake: sinus rhythm at 88 per minute, normal intervals, no ischemic change1991-05-08 to 1991-05-08completedS
Radioactive iodine (iodine-131, 15 mCi by mouth) for Graves' disease, with written radiation-safety instructions1991-05-29 to 1991-05-29completedS
14-day ambulatory ECG patch: sinus rhythm throughout, no atrial fibrillation or flutter, rare atrial ectopic beats1991-08-24 to 1991-09-07completedS
Advance care planning conversation, about 20 minutes1991-10-16 to 1991-10-16completedS

Immunizations

DateVaccineStatusEvidence
1990-10-14High-dose influenza vaccine, 1990-1991 seasoncompletedS
1989-10-08Pneumococcal conjugate vaccine PCV20completedS
1987-03-15Recombinant zoster vaccine, two-dose series completedcompletedS
1991-10-16High-dose influenza vaccine, 1991-1992 seasoncompletedS
1991-10-16Tdap vaccinecompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
May 4, 1991Atrial fibrillation that began as unusual fatigue while running; hospital stay of two days, with normal ECG apart from the rhythm and a normal cardiac ultrasound; sinus rhythm restored on medication without cardioversionD (CLM-0002, CLM-0003, CLM-0004)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
New irregular heartbeat that began as unusual tiredness on a run; wants to know whether he can keep runningactiveS
Wants to get back to a full working schedule and to exercise as soon as it is safeactiveS

Assessment

Most recent measures: Thyrotropin [Units/volume] in Serum or Plasma 2.6 on 1991-10-16; Thyroxine (T4) free [Mass/volume] in Serum or Plasma 0.9 on 1991-09-11; Triiodothyronine (T3) [Mass/volume] in Serum or Plasma 78 on 1991-07-17; Thyrotropin receptor Ab [Units/volume] in Serum 8.2 on 1991-05-08; Leukocytes [#/volume] in Blood by Automated count 6.8 on 1991-05-08; Neutrophils [#/volume] in Blood by Automated count 3.5 on 1991-05-20; Hemoglobin [Mass/volume] in Blood 14.8 on 1991-05-08; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30 on 1991-05-20; Creatinine [Mass/volume] in Serum or Plasma 0.92 on 1991-05-08; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1986)/1.73 sq M 87 on 1991-05-08; Potassium [Moles/volume] in Serum or Plasma 4.2 on 1991-05-08; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1991-10-16; Total score [Mini-Cog] 5 on 1991-10-16; Total score [AUDIT-C] 1 on 1991-10-16; Cholesterol [Mass/volume] in Serum or Plasma 186 on 1991-10-16; Cholesterol in HDL [Mass/volume] in Serum or Plasma 58 on 1991-10-16; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 108 on 1991-10-16; Triglyceride [Mass/volume] in Serum or Plasma 100 on 1991-10-16; Hemoglobin A1c/Hemoglobin.total in Blood 5.4 on 1991-10-16 [S]

Strengths and supports: Supports: spouse, adult children, and close colleagues and friends [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Paroxysmal atrial fibrillation, first detected four days before intake while running, triggered by hyperthyroidism; CHA2DS2-VASc 1; synthetic modern episode linked to his documented atrial fibrillationactiveconfirmed I48.0S — Synthetic modern classification of a documented arrhythmia.
Graves' disease with hyperthyroidism; synthetic modern diagnosis linked to his documented Graves' diseaseactiveconfirmed E05.00S — Synthetic modern diagnosis confirmed by thyroid tests and TSH receptor antibody; the historical diagnosis is D.
Hypothyroidism after radioactive iodine, on levothyroxine replacementactiveconfirmed E89.0S — Synthetic modern diagnosis linked to his documented hypothyroidism and lifelong thyroid hormone.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1991-05-08Thyrotropin [Units/volume] in Serum or Plasma0.005m[IU]/L0.4-4 mIU/LLowS
1991-05-08Thyroxine (T4) free [Mass/volume] in Serum or Plasma3.6ng/dL0.8-1.8 ng/dLHighS
1991-05-08Triiodothyronine (T3) [Mass/volume] in Serum or Plasma280ng/dL80-200 ng/dLHighS
1991-05-08Thyrotropin receptor Ab [Units/volume] in Serum8.2[IU]/L<=1.75 [IU]/LHighS
1991-05-08Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
1991-05-08Neutrophils [#/volume] in Blood by Automated count3.910*3/uL1.5-7.5 10*3/uLNormalS
1991-05-08Hemoglobin [Mass/volume] in Blood14.8g/dL13.5-17.5 g/dLNormalS
1991-05-08Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma32U/L7-55 U/LNormalS
1991-05-08Creatinine [Mass/volume] in Serum or Plasma0.92mg/dL0.7-1.3 mg/dLNormalS
1991-05-08Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1986)/1.73 sq M87mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1991-05-08Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
1991-05-20Thyrotropin [Units/volume] in Serum or Plasma0.01m[IU]/L0.4-4 mIU/LLowS
1991-05-20Thyroxine (T4) free [Mass/volume] in Serum or Plasma2.2ng/dL0.8-1.8 ng/dLHighS
1991-05-20Triiodothyronine (T3) [Mass/volume] in Serum or Plasma176ng/dL80-200 ng/dLNormalS
1991-05-20Neutrophils [#/volume] in Blood by Automated count3.510*3/uL1.5-7.5 10*3/uLNormalS
1991-05-20Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma30U/L7-55 U/LNormalS
1991-07-17Thyrotropin [Units/volume] in Serum or Plasma5.6m[IU]/L0.4-4 mIU/LHighS
1991-07-17Thyroxine (T4) free [Mass/volume] in Serum or Plasma0.6ng/dL0.8-1.8 ng/dLLowS
1991-07-17Triiodothyronine (T3) [Mass/volume] in Serum or Plasma78ng/dL80-200 ng/dLLowS
1991-09-11Thyrotropin [Units/volume] in Serum or Plasma6.4m[IU]/L0.4-4 mIU/LHighS
1991-09-11Thyroxine (T4) free [Mass/volume] in Serum or Plasma0.9ng/dL0.8-1.8 ng/dLNormalS
1991-10-16Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1991-10-16Total score [Mini-Cog]5{score}S
1991-10-16Total score [AUDIT-C]1{score}S
1991-10-16Thyrotropin [Units/volume] in Serum or Plasma2.6m[IU]/L0.4-4 mIU/LNormalS
1991-10-16Cholesterol [Mass/volume] in Serum or Plasma186mg/dL<=200 mg/dLNormalS
1991-10-16Cholesterol in HDL [Mass/volume] in Serum or Plasma58mg/dL>=40 mg/dLNormalS
1991-10-16Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation108mg/dL<=129 mg/dLNormalS
1991-10-16Triglyceride [Mass/volume] in Serum or Plasma100mg/dL<=149 mg/dLNormalS
1991-10-16Hemoglobin A1c/Hemoglobin.total in Blood5.4%<=5.6%NormalS

Social History

Vital Signs

DateMeasureValueUnitProvenance
1991-05-08Body height188cmS
1991-05-08Body weight86kgS
1991-05-08Body mass index (BMI) [Ratio]24.3kg/m2S
1991-05-08Systolic blood pressure142mm[Hg]S
1991-05-08Diastolic blood pressure68mm[Hg]S
1991-05-08Heart rate88/minS
1991-05-08Respiratory rate16/minS
1991-05-08Body temperature37.1CelS
1991-05-08Oxygen saturation in Arterial blood by Pulse oximetry98%S
1991-05-20Body height188cmS
1991-05-20Body weight86.4kgS
1991-05-20Body mass index (BMI) [Ratio]24.4kg/m2S
1991-05-20Systolic blood pressure132mm[Hg]S
1991-05-20Diastolic blood pressure70mm[Hg]S
1991-05-20Heart rate72/minS
1991-05-20Respiratory rate14/minS
1991-05-20Body temperature36.9CelS
1991-05-20Oxygen saturation in Arterial blood by Pulse oximetry98%S
1991-07-17Body height188cmS
1991-07-17Body weight88.6kgS
1991-07-17Body mass index (BMI) [Ratio]25.1kg/m2S
1991-07-17Systolic blood pressure128mm[Hg]S
1991-07-17Diastolic blood pressure76mm[Hg]S
1991-07-17Heart rate64/minS
1991-07-17Respiratory rate14/minS
1991-07-17Body temperature36.6CelS
1991-07-17Oxygen saturation in Arterial blood by Pulse oximetry98%S
1991-09-11Body height188cmS
1991-09-11Body weight90.2kgS
1991-09-11Body mass index (BMI) [Ratio]25.5kg/m2S
1991-09-11Systolic blood pressure126mm[Hg]S
1991-09-11Diastolic blood pressure76mm[Hg]S
1991-09-11Heart rate62/minS
1991-09-11Respiratory rate14/minS
1991-09-11Body temperature36.6CelS
1991-09-11Oxygen saturation in Arterial blood by Pulse oximetry98%S
1991-10-16Body height188cmS
1991-10-16Body weight90.8kgS
1991-10-16Body mass index (BMI) [Ratio]25.7kg/m2S
1991-10-16Systolic blood pressure128mm[Hg]S
1991-10-16Diastolic blood pressure78mm[Hg]S
1991-10-16Heart rate68/minS
1991-10-16Respiratory rate14/minS
1991-10-16Body temperature36.7CelS
1991-10-16Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1991-05-08Post-hospital visit for new atrial fibrillation, with thyroid tests showing hyperthyroidismfinishedS
1991-05-20Two-week review on methimazole, with endocrinology consultationfinishedS
1991-07-17Seven-week review after radioactive iodinefinishedS
1991-09-11Four-month review: levothyroxine titration and anticoagulation decisionfinishedS
1991-10-16Subsequent annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Rate control with metoprolol succinate 50 mg daily; no antiarrhythmic drug or cardioversion while thyrotoxic, because most thyrotoxic atrial fibrillation reverts once thyroid levels are normal; taper the beta-blocker once he is no longer thyrotoxiccompletedGL-ACC-AF-2023, GL-CMID-2026, GL-ATA-HYPER-2016S
Stroke-risk and bleeding-risk scoring (CHA2DS2-VASc 1 for age 65 to 74; HAS-BLED 1 for age over 65) with a shared decision to continue apixaban 5 mg twice daily while thyrotoxic, then reassess once sustained sinus rhythm is confirmed after he is no longer thyrotoxiccompletedGL-ACC-AF-2023, GL-CMID-2026S
Methimazole 20 mg daily after a baseline blood count and liver tests, with written advice to stop it and call at once for fever, sore throat, mouth ulcers, jaundice, or dark urine; stop three days before radioactive iodinecompletedGL-ATA-HYPER-2016S
Endocrinology consultation to confirm Graves' disease, assess the eyes, and choose definitive treatment (radioactive iodine, long-term methimazole, or surgery)completedGL-ATA-HYPER-2016S
After radioactive iodine: free T4 and total T3 within one to two months and then every four to six weeks until stable; levothyroxine once hypothyroid, started below full replacement; TSH four to eight weeks after each dose change, at six months once stable, then yearly; target TSH 0.4 to 4.0 mIU/LcompletedGL-ATA-HYPER-2016, GL-ATA-HYPO-2014, GL-CMID-2026S
Atrial fibrillation monitoring at every visit (heart rate and rhythm, blood pressure, weight, symptoms, activity, alcohol, tobacco), ECG when indicated, echocardiogram at diagnosis, CHA2DS2-VASc and HAS-BLED yearly, creatinine and blood count at baseline and yearly on apixaban, and sleep apnea screening at diagnosis and yearlycompletedGL-ACC-AF-2023, GL-CMID-2026S
Return to running in steps once the heart rate is controlled, aiming for about 210 minutes a week of moderate to vigorous activity; limit alcohol to no more than one drink a daycompletedGL-ACC-AF-2023, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Resting heart rate below 110 per minute without palpitations while thyrotoxic1991-05-20completedHeart rate 72 in sinus rhythm on metoprolol two weeks after intakeS
No atrial fibrillation once no longer thyrotoxic, confirmed by ambulatory monitoring before the anticoagulation decision1991-09-11completedSinus rhythm throughout a 14-day ECG patchS
TSH within 0.4 to 4.0 mIU/L on levothyroxine1991-10-16completedTSH 6.4 on 75 mcg at the four-month review; 2.6 five weeks after the increase to 100 mcgS
Back to running three miles several days a week without symptoms1991-09-11completedRunning three miles four days a week without palpitationsS

Functional Status

Mental Status